查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1673943

EPA 和 DHA 市場按來源、形式、用途和地區分類

EPA and DHA Market, By Source, By Form, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計 2025 年全球 EPA 和 DHA 市場規模為 20.7 億美元，2032 年將達到 33.2 億美元，2025 年至 2032 年的年複合成長率為 7.0%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 20.7億美元
效能資料 2020-2024 預測期 2025-2032
預測期：2025 年至 2032 年複合年成長率 7.00％ 2032 年金額預測 33.2億美元
數字。 EPA 和 DHA 市場區域佔有率（%）（2025 年）
EPA 和 DHA 市場-IMG1

由於消費者健康意識的增強以及含有這些關鍵的Omega-3脂肪酸的補充劑的普及，全球 EPA 和 DHA 市場正在經歷顯著成長。 EPA 和 DHA 是源自海洋的多不飽和脂肪酸，對大腦、眼睛和心血管健康發揮重要作用。隨著老齡化社會的推進，文明病的蔓延推動了對 EPA 和 DHA 補充劑的需求增加。各種臨床研究已經證明了 EPA 和 DHA 的深遠益處，包括減少發炎、降低心臟病的風險和改善神經功能。隨著科學證據的增加，越來越多的人從食物和補充劑中獲得這些必需脂肪酸。

市場動態

隨著消費者對 EPA 和 DHA 的健康益處以及慢性病流行的認知不斷提高，推動了 EPA 和 DHA 補充劑的全球銷售。然而，原料採購成本高對市場進入者來說是一個重大挑戰。魚油的充足供應和Omega-3脂肪酸的素食替代品的出現為市場擴張提供了有利可圖的機會。持續研究和開發新的應用可能會擴大 EPA 和 DHA 的臨床用途和市場範圍。

研究的主要特點

本報告對全球 EPA 和 DHA 市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設基準年為 2024 年。

它還揭示了各個領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球 EPA 和 DHA 市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。

研究中介紹的主要企業包括荷蘭皇家帝斯曼集團 (Koninklijke DSM NV)、KD Pharma Group、阿徹丹尼爾斯米德蘭公司 (The Archer Daniels Midland Company)、Corbion NV、Novasep Holding SAS、Neptune Wellness Solutions、 BASF SE、Omegas Ltd. operative Group Limited)。

本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球 EPA 和 DHA 市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

預計相關人員將透過分析全球 EPA 和 DHA 市場所使用的各種策略矩陣來促進他們的決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 影響分析
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 市場機會
  • 監管情景
  • 產業趨勢

4. 2020 年至 2032 年全球 EPA 與 DHA 市場來源分佈（十億美元）

  • 介紹
  • 魚油
  • 藻油
  • 磷蝦油
  • 其他

5. 2020 年至 2032 年全球 EPA 和 DHA 市場（按形式分類）（十億美元）

  • 介紹
  • 液體
  • 膠囊和軟膠囊
  • 粉末
  • 其他

6. 2020 年至 2032 年全球 EPA 和 DHA 市場（按應用分類）（十億美元）

  • 介紹
  • 營養補充品
  • 飲食
  • 藥品
  • 其他

7. 2020 年至 2032 年全球 EPA 和 DHA 市場（按地區分類）（十億美元）

  • 介紹
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭格局

  • Koninklijke DSM NV
  • KD Pharma Group
  • The Archer Daniels Midland Company
  • Corbion NV
  • Novasep Holding SAS
  • Neptune Wellness Solutions
  • BASF SE
  • Omega Protein Corporation
  • Croda International PLC
  • Novotech Nutraceuticals
  • Herbalife Nutrition Ltd.
  • Fonterra Co-operative Group Limited

第 9 章分析師建議

  • 興衰
  • 一致的機會地圖

第10章參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5200

Global EPA and DHA Market is estimated to be valued at USD 2.07 Bn in 2025 and is expected to reach USD 3.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.07 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.00% 2032 Value Projection: USD 3.32 Bn
Figure. EPA And DHA Market Share (%), By Region 2025
EPA and DHA Market - IMG1

Global EPA and DHA market has been witnessing significant growth due to rising health consciousness among consumers and growing adoption of supplements containing these key omega-3 fatty acids. EPA and DHA are polyunsaturated fatty acids found in marine sources that play an important role in brain and eye health as well as cardiovascular health. Increasing prevalence of lifestyle diseases along with growing aging population has boosted the demand for EPA and DHA supplements. Various clinical studies have demonstrated the far-ranging benefits of EPA and DHA in reducing inflammation, lowering risk of heart disease, and improving neurological functioning. With growing scientific evidence, more people are incorporating these essential fatty acids into their diets through food sources as well as supplements.

Market Dynamics

Increasing consumer awareness about EPA and DHA health benefits and prevalence of chronic diseases boosts sales of EPA and DHA supplements globally. However, high procurement cost of raw materials poses major challenge for market players. Abundant availability of fish oils as well as emergence of alternative vegan sources of omega-3 fatty acids present lucrative opportunities for the market expansion. Sustained R&D into new applications can expand the clinical uses and market outreach of EPA and DHA.

Key Features of the Study

This report provides in-depth analysis of the global EPA and DHA market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global EPA and DHA market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Koninklijke DSM NV, KD Pharma Group, The Archer Daniels Midland Company, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Omega Protein Corporation, Croda International PLC, Novotech Nutraceuticals, Herbalife Nutrition Ltd., and Fonterra Co-operative Group Limited

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global EPA and DHA market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global EPA and DHA market

Market Segmentation

  • By Source Insights (Revenue, USD Bn, 2020 - 2032)
    • Fish Oil
    • Algal Oil
    • Krill Oil
    • Others
  • By Form Insights (Revenue, USD Bn, 2020 - 2032)
    • Liquid
    • Capsules and Soft gels
    • Powder
    • Others
  • By Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Dietary Supplements
    • Food and Beverages
    • Pharmaceuticals
    • Others
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Koninklijke DSM NV
    • KD Pharma Group
    • The Archer Daniels Midland Company
    • Corbion NV
    • Novasep Holding SAS
    • Neptune Wellness Solutions
    • BASF SE
    • Omega Protein Corporation
    • Croda International PLC
    • Novotech Nutraceuticals
    • Herbalife Nutrition Ltd.
    • Fonterra Co-operative Group Limited

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global EPA and DHA Market, By Source
    • Global EPA and DHA Market, By Form
    • Global EPA and DHA Market, By Application
    • Global EPA and DHA Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trend

4. Global EPA and DHA Market, By Source, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Fish Oil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Algal Oil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Krill Oil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global EPA and DHA Market, By Form, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Liquid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Capsules and Soft gels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Powder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global EPA and DHA Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Dietary Supplements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Food and Beverages
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pharmaceuticals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global EPA and DHA Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Koninklijke DSM NV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • KD Pharma Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • The Archer Daniels Midland Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Corbion NV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novasep Holding SAS
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neptune Wellness Solutions
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Omega Protein Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Croda International PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novotech Nutraceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Herbalife Nutrition Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fonterra Co-operative Group Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us